• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

    594.02 +9.11 (+1.56%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Medpace Holdings, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    1 Mid-Cap Stock to Target This Week and 2 We Ignore
    Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
    Via StockStory
    3 Cash-Heavy Stocks Worth Your Attention
    In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence. These cash-heavy companies shine bright for their financial discipline, resilience, and... 
    Via StockStory
    5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call
    Medpace’s third quarter results were well received by the market, driven by broad-based revenue growth and robust net new business awards. Management credited strong demand across therapeutic... 
    Via StockStory
    Topics Earnings
    Preview: Medpace Hldgs's Earnings
     
    Via Benzinga
    8 Analysts Assess Medpace Hldgs: What You Need To Know
     
    Via Benzinga
    Medpace Soars: AI and Data Analytics Propel Clinical Trial Giant to Record Heights
    Medpace Holdings, Inc. (NASDAQ: MEDP), a leading global contract research organization (CRO), has been experiencing an unprecedented surge in its stock value, reaching an all-time high of $543.90 on... 
    Via TokenRing AI
    Topics Artificial Intelligence
    Why Medpace Popped 13% This Week
    The biopharmaceutical processor posted another strong earnings result for the third quarter. 
    Via The Motley Fool
    Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings
     
    Via Benzinga
    MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook
    Clinical research company Medpace Holdings (NASDAQ:MEDP) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 23.7% year on year to $659.9 million. The company’s full-year... 
    Via StockStory
    Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
    Medpace shares climb as Q3 earnings and revenue top estimates, driven by strong bookings, rising backlog, and an upbeat 2025 guidance. 
    Via Benzinga
    Topics Earnings
    Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday
     
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Stock Market Today: Dow Jones, Nasdaq Futures Tumble Amid US-China Trade Tensions—Tesla, IBM, American Airlines In Focus
    U.S. stock futures were swinging on Thursday following Wednesday’s declines. Futures of major benchmark indices were lower. 
    Via Benzinga
    Topics Stocks
    MEDPACE HOLDINGS INC (NASDAQ:MEDP) Emerges as a Top Growth and Momentum Pick
    MEDP Holdings stock shows strong technical and fundamental growth momentum, meeting strict trend-following criteria for a powerful setup. 
    Via Chartmill
    Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike
    Medpace stock rocketed late Wednesday on "another strong Q," that included double-digit sales and profit growth. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's After-Market Session
     
    Via Benzinga
    Medpace Holdings Inc (NASDAQ:MEDP) Tops Q3 2025 Earnings and Revenue Estimates
    Medpace (MEDP) Q3 2025 earnings beat analyst forecasts with strong revenue and EPS growth. The CRO also reported robust bookings and raised its full-year guidance. 
    Via Chartmill
    Topics Earnings
    Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5%
    Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 23.7% year on year to $659.9 million. The company’s... 
    Via StockStory
    Which stocks are moving after the closing bell on Wednesday?
    Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
    Via Chartmill
    Earnings Scheduled For October 22, 2025
     
    Via Benzinga
    Medpace (MEDP) Reports Earnings Tomorrow: What To Expect
    Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results this Wednesday afternoon. Here’s what to expect. 
    Via StockStory
    1 High-Flying Stock to Research Further and 2 That Underwhelm
    Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,... 
    Via StockStory
    Topics Supply Chain
    1 Volatile Stock Worth Investigating and 2 That Underwhelm
    A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
    Via StockStory
    Medpace and Revvity Stocks Trade Down, What You Need To Know
    A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
    Via StockStory
    Topics Economy Government World Trade
    3 Market-Beating Stocks with Competitive Advantages
    The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
    Via StockStory
    Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
    As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
    Via StockStory
    This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
     
    Via Benzinga
    Why Medpace (MEDP) Stock Is Trading Lower Today
    Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.2% in the morning session after Barclays downgraded the stock to "Underweight" from "Equal-Weight" and reduced its price... 
    Via StockStory
    Breaking Down Medpace Hldgs: 10 Analysts Share Their Views
     
    Via Benzinga
    1 Healthcare Stock with Exciting Potential and 2 We Ignore
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
    Via StockStory
    Topics Stocks
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.